Showing results (1-10 of 189) with videos related to

Sort By:
Pageof 19
Cellular and Molecular Life Sciences : CMLS|December 29, 2012
Do we need pharmacogenetics to personalize antidepressant therapy?Cristina Lanni, Marco Racchi, Stefano Govoni
Alzheimer'S & Dementia (New York, N. Y.)|July 17, 2020
Targeting dementias through cancer kinases inhibitionFrancesca Fagiani, Cristina Lanni, Marco Racchi, et al.
Molecular Neurobiology|October 21, 2020
The Peptidyl-prolyl Isomerase Pin1 in Neuronal Signaling: from Neurodevelopment to NeurodegenerationFrancesca Fagiani, Stefano Govoni, Marco Racchi, et al.
Frontiers in Molecular Neuroscience|March 15, 2021
(Dys)regulation of Synaptic Activity and Neurotransmitter Release by β-Amyloid: A Look Beyond Alzheimer's Disease PathogenesisFrancesca Fagiani, Cristina Lanni, Marco Racchi, et al.
Molecular Psychiatry|May 9, 2020
Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathwaysCristina Lanni, Mirco Masi, Marco Racchi, et al.
European Journal of Biochemistry|July 6, 2004
Differential involvement of protein kinase C alpha and epsilon in the regulated secretion of soluble amyloid precursor proteinCristina Lanni, Michela Mazzucchelli, Emanuela Porrello, et al.
Journal of Alzheimer'S Disease : JAD|September 29, 2019
Amyloid-β and Synaptic Vesicle Dynamics: A Cacophonic OrchestraFrancesca Fagiani, Cristina Lanni, Marco Racchi, et al.
Pharmacological Research|June 22, 2010
beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domainErica Buoso, Cristina Lanni, Gennaro Schettini, et al.
Pharmacological Research|August 12, 2004
Acetylcholinesterase inhibitors: novel activities of old moleculesMarco Racchi, Michela Mazzucchelli, Emanuela Porrello, et al.
Journal of Alzheimer'S Disease : JAD|September 14, 2007
Unfolded p53: a potential biomarker for Alzheimer's diseaseCristina Lanni, Daniela Uberti, Marco Racchi, et al.
Pageof 19